The company has a R&D center of nearly 1000 m²。The core R&D team is made of industrial and academic experts in regulated cell death and related pathogenesis in human diseases. In its journey toward developing innovative medicines, the Company has also recruited a number of industrial veterans in Medicinal Chemistry, Pharmacology, Toxicology, DMPK, CMC, Clinical Studies, etc. Among them, 25% are PhD & MD, and 53% are master.